Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Parkes

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Oncologist|August 19, 2018
Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only MetastasesAmanda Parkes, Carla L Warneke, Katherine Clifton, et al.
The Lancet. Oncology|September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b studyKelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Cancer Medicine|March 28, 2022
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancyDevon Miller, John A Livingston, Yeonhee Park, et al.
BMC Cancer|March 9, 2023
Spatial characterization and quantification of CD40 expression across cancer typesKatherine M Bates, Ioannis Vathiotis, Tyler MacNeil, et al.
Journal of Oncology Practice|April 17, 2019
Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community HospitalAmanda Parkes, Maliha Nusrat, Pamela Maree Di Tomasso, et al.
Breast Cancer Research and Treatment|February 12, 2021
Outcomes of systemic therapy in metastatic phyllodes tumor of the breastAmanda Parkes, Wei-Lien Wang, Shreyaskumar Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2020
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapyAngela C Hirbe, Vanessa Eulo, Chang I Moon, et al.
Genes|November 11, 2022
The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective AnalysisLawrence Liu, Carina Dehner, Nikhil Grandhi, et al.
Sarcoma|June 23, 2020
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated LiposarcomaAmanda Parkes, Elizabeth Urquiola, Priya Bhosale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial UpdateAfshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Oncologist|August 19, 2018
Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only MetastasesAmanda Parkes, Carla L Warneke, Katherine Clifton, et al.
The Lancet. Oncology|September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b studyKelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Cancer Medicine|March 28, 2022
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancyDevon Miller, John A Livingston, Yeonhee Park, et al.
BMC Cancer|March 9, 2023
Spatial characterization and quantification of CD40 expression across cancer typesKatherine M Bates, Ioannis Vathiotis, Tyler MacNeil, et al.
Journal of Oncology Practice|April 17, 2019
Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community HospitalAmanda Parkes, Maliha Nusrat, Pamela Maree Di Tomasso, et al.
Breast Cancer Research and Treatment|February 12, 2021
Outcomes of systemic therapy in metastatic phyllodes tumor of the breastAmanda Parkes, Wei-Lien Wang, Shreyaskumar Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2020
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapyAngela C Hirbe, Vanessa Eulo, Chang I Moon, et al.
Genes|November 11, 2022
The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective AnalysisLawrence Liu, Carina Dehner, Nikhil Grandhi, et al.
Sarcoma|June 23, 2020
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated LiposarcomaAmanda Parkes, Elizabeth Urquiola, Priya Bhosale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial UpdateAfshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, et al.
Pageof 4